Lobbying activity

Q1

LMH STRATEGIC SOLUTIONS for ARDELYX, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $30,000.00 income

Health Issues, Pharmacy

View → Q1

ARENTFOX SCHIFF LLP for PHARVARIS, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $40,000.00 income

Medicare/Medicaid, Pharmacy

View → 1@

BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES

1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate

Medicare/Medicaid, Pharmacy

View → 1T

BRIGHTSPRING HEALTH SERVICES for BRIGHTSPRING HEALTH SERVICES

1st Quarter (Jan 1 - Mar 31) 2026 · Kentucky · House · Senate

Medicare/Medicaid, Pharmacy

View → Q1

AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY for AMERICAN ACADEMY OF OTOLARYNGOLOGY-HEAD AND NECK SURGERY

1st Quarter (Jan 1 - Mar 31) 2026 · Virginia · House · Senate

Medicare/Medicaid, Budget/Appropriations, Education, Insurance

View → Q1

VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · Senate · $30,000.00 income

Consumer Issues/Safety/Products, Pharmacy

View → Q1

BOLD STRATEGIES, LLC for MORRIS & DICKSON CO., LLC

1st Quarter (Jan 1 - Mar 31) 2026 · Louisiana · House · Senate · $10,000.00 income

Health Issues, Pharmacy

View → Q1

MARSHALL & POPP, LLC for GLAXOSMITHKLINE

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $20,000.00 income

Pharmacy

View → Q1

MARSHALL & POPP, LLC for SUN PHARMACEUTICAL INDUSTRIES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $40,000.00 income

Pharmacy

View → Q1

MARSHALL & POPP, LLC for SANOFI U.S. SERVICES, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark

View → Q1

MARSHALL & POPP, LLC for PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $40,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for PFIZER, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Trade (domestic/foreign), Taxation/Internal Revenue Code, Pharmacy, Copyright/Patent/Trademark

View → Q1

MARSHALL & POPP, LLC for GENENTECH, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for ELI LILLY AND COMPANY

1st Quarter (Jan 1 - Mar 31) 2026 · Indiana · House · Senate · $60,000.00 income

Medicare/Medicaid, Pharmacy

View → Q1

MARSHALL & POPP, LLC for DAIICHI SANKYO, INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate

Pharmacy

View → Q1

MARSHALL & POPP, LLC for CSL BEHRING

1st Quarter (Jan 1 - Mar 31) 2026 · Pennsylvania · House · Senate · $50,000.00 income

Pharmacy, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for BRISTOL-MYERS SQUIBB COMPANY

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · House · Senate · $40,000.00 income

Pharmacy

View → Q1

MARSHALL & POPP, LLC for BRIDGEBIO PHARMA

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $60,000.00 income

Pharmacy

View → Q1

MARSHALL & POPP, LLC for AMGEN USA INC.

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income

Pharmacy, Copyright/Patent/Trademark, Trade (domestic/foreign)

View → Q1

MARSHALL & POPP, LLC for ABBVIE INC.

1st Quarter (Jan 1 - Mar 31) 2026 · Illinois · House · Senate · $60,000.00 income

Pharmacy

View → 1T

SALT POINT STRATEGIES for VERTEX PHARMACEUTICALS

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts · House · Senate · $10,000.00 income

Pharmacy

View → RR

LMH STRATEGIC SOLUTIONS for MIDSIZED BIOTECH ALLIANCE OF AMERICA (MBAA)

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia

Pharmacy, Medicare/Medicaid

View → RR

LMH STRATEGIC SOLUTIONS for BICYCLE THERAPEUTICS

1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts

Health Issues, Pharmacy

View → 4T

LMH STRATEGIC SOLUTIONS for EXELIXIS, INC.

4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate · $30,000.00 income

Pharmacy, Medicare/Medicaid

View → Q1

BALLARD PARTNERS for NOVO NORDISK INC.

1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey · $120,000.00 income

Pharmacy

View →